Graviton Bioscience
Amy Melsaether, MD is currently serving as the Chief Medical Officer at Graviton Bioscience. Previously, Amy held the position of Senior Vice President Consultant, Clinical Research at Équilibre Biopharmaceuticals. Prior to their roles in the pharmaceutical industry, Amy was an Associate Professor of Radiology at Icahn School of Medicine at Mount Sinai and NYU Langone Medical Center. Amy holds a Doctor of Medicine degree from the David Geffen School of Medicine at UCLA, with a background in Biochemistry, Molecular Biology, and English from the University of Wisconsin-Madison.
Graviton Bioscience
Graviton Bioscience, a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2), along with other therapeutic compounds.